Drug Shortage Report for MINT-ONDANSETRON
Report ID | 27173 |
Drug Identification Number | 02305267 |
Brand name | MINT-ONDANSETRON |
Common or Proper name | Ondansetron |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 8MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | Bottles of 30 |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-07-14 |
Estimated end date | Unknown |
Actual end date | 2017-11-21 |
Shortage status | Resolved |
Updated date | 2017-11-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-11-22 | English | Compare |
v4 | 2017-11-21 | French | Compare |
v3 | 2017-11-21 | English | Compare |
v2 | 2017-10-26 | French | Compare |
v1 | 2017-10-26 | English | Compare |
Showing 1 to 5 of 5